A kidney disease moonshot is long overdue
What we need is a new “moonshot” for kidney care — that mirrors previous initiatives to tackle cancer. We need the collective energy, focus, incentives, and resources of both government and stakeholders — to bring diagnosis, treatment, access, choice, and delivery of quality kidney care into the 21st century. This will by far be our…
On World Kidney Day, the Kidney Community Acknowledges the Historic Alignment Between Public and Private Stakeholders on Key Policies to Improve Access, Choice and Innovation in Kidney Care
WASHINGTON, DC—Kidney Care Partners (KCP) – the nation’s leading coalition of more than 30 organizations comprised of patient advocates, dialysis professionals, care providers, researchers and manufacturers – acknowledges the historic alignment to address the public health care challenge among millions of Americans living with kidney disease. The Administration, Congress and the broader kidney care community…
Capitol Hill Briefing: The Future of Kidney Care in America
**In light of the coronavirus (COVID-19) outbreak situation, this briefing has been canceled and will be rescheduled for a later date.** We apologize for the inconvenience and thank you for your understanding. Participants from Congress, HHS, NIH and the Kidney Community will Discuss Bold Actions to Expand Choice, Improve Access and Foster Innovation in Kidney…
Nation’s Kidney Community Applauds Introduction of Legislation to Expand Access to Treatments for Individuals with Kidney Transplants
Bipartisan, Bicameral Legislation Would Extend Medicare Coverage of Immunosuppressive Drugs for Individuals with Kidney Transplants WASHINGTON, DC – Kidney Care Partners (KCP) – the nation’s leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers and manufacturers – today praised the introduction of the Comprehensive Immunosuppressive Drug Coverage for Kidney…
Statement from Kidney Care Partners on the Center for Medicare & Medicaid Services’ Proposed Changes to Medicare Advantage
Washington, DC — In response to the Centers for Medicare & Medicaid Services’ (CMS) announcement on proposed changes to the Medicare Advantage (MA) program, Kidney Care Partners (KCP) reiterated its strong support for action to provide Medicare beneficiaries with kidney failure – or end-stage renal disease (ESRD) — with access to MA plans. However, KCP…
MedPAC Eyes Axing ESRD Drug Add-On Pay As Trump Touts Kidney Care
Some kidney care stakeholders say the Medicare Payment Advisory Commission seems to be at odds with the administration over the need for innovation in treatments for end stage renal disease patients after commissioners at their January meeting leaned toward eliminating the transitional drug add-on payment adjustment to the ESRD pay bundle. But the payment advisors…
John P. Butler, President and CEO of Akebia Therapeutics, Takes Helm as New Chair of Nation’s Largest Kidney Coalition
Butler will focus on supporting innovation to improve patient-centric care for individuals living with kidney disease, kidney failure and transplants Washington, DC—Kidney Care Partners (KCP) – the nation’s leading kidney care coalition composed of patients, caregivers, providers, researchers and manufacturers – is pleased to announce John P. Butler as its new chair. Butler, a long-standing…
Patients need cohesive health care coverage to cope with kidney disease
From the perspective of policy makers, patient advocates and health care providers, chronic kidney disease and kidney failure present the following series of important questions: How do we, as a nation, tackle the economic and physical implications of a health care epidemic that when undiagnosed or left untreated, results in loss of vital organ function…
Kidney Care Community Encouraged by New USRDS Data, Stresses the Need for Continued Improvement
The latest United States Renal Data System (USRDS) report underscores the need to expand education and early detection efforts to improve health outcomes WASHINGTON, DC – Kidney Care Partners (KCP) – the nation’s leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers and manufacturers – today expressed optimism that…
Awareness and prevention needed to slow progression of CKD
It is a sad fact that – even as prevalent as kidney disease has become in the United States – many Americans have no idea that, albeit silently, their kidney function is deteriorating. As we know, there are often few obvious, outward signs. Genetics and race play a role; but whereas people might be aware…